Cycled Phototherapy
Trial ID or NCT#
NCT03927833
Status
RECRUITING
Purpose
Cycled phototherapy (PT) is likely to increase survival over that with continuous PT among extremely premature infants (< 750 g BW or <27 weeks GA).
Official Title
Cycled Phototherapy: A Safer Effective Method to Control the Serum Bilirubin Of Extremely Premature Infants?
Eligibility Criteria
Ages Eligible for Study: 22 Weeks to 27 Weeks
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- 1. Infants is inborn 2. Infant is ≤ 750 grams at birth and/or < 27 weeks gestation at birth by best OB estimate 3. Infant is 12-36 hours of age.
Exclusion Criteria:
- 1. Unable to enroll infant by 36 hours of age 2. Previous phototherapy 3. Known hemolytic disease 4. TSB reported as >6.0 mg/dL before 12 hours age 5. Major anomaly 6. Overt nonbacterial infection 7. Infant is likely to expire soon: Limiting or withdrawal of intensive care is being recommended to the parents, the parents are requesting withdrawal of care, or the pH is < 6.80 or persistent bradycardia with hypoxemia for >2h.
Investigator(s)
Krisa Van Meurs
Contact us to find out if this trial is right for you.
Contact
M. Bethany Ball
723-5711
View on ClinicalTrials.gov
